TOTAL VOLUME:
$134b
24H VOL:
$85,014,378
24H TRANSACTIONS:
2,388,728,490
OPEN INTEREST:
$1,391,695,592
394,774
Markets across
30,069
events
MATCHED EVENTS:
2,615
PLATFORM COVERAGE:
5
Polymarket:
39%
VS.
Kalshi:
61%
Closed: Aug 19, 4:48 PM EST
Kalshi
This market on Kalshi tracks which individual Trump will nominate to lead the FDA before the presidential term concludes. Kyle Diamantas currently shows 27.0% probability as the leading candidate, while Mehmet Oz follows at 14.0%. Resolution is determined by official nomination announcements verified through public sources. Watch for Trump's formal FDA commissioner nomination announcement before January 20, 2029, which will trigger market resolution.
The market resolves based on which individual receives an official nomination for FDA commissioner after market issuance and before January 20, 2029. Only the first official nomination made after issuance will be considered for resolution purposes.
Key catalysts include Trump's public statements or social media posts naming or praising potential FDA commissioners, media reports about transition team deliberations, and announcements of other cabinet positions that may signal his policy direction on drug regulation. Senate confirmation hearings or vetting controversies surrounding leading candidates could shift odds sharply. Industry lobbying, pharmaceutical sector reactions, and statements from Trump allies about FDA reform priorities may also influence trader expectations. Finally, any withdrawal or public disinterest from a frontrunner candidate would immediately reprrice the market toward alternative nominees.